Skip to main content
Premium Trial:

Request an Annual Quote

Cell Microsystems Raises $10M in Growth Funding

NEW YORK – Cell Microsystems said on Monday that it closed $10 million in growth financing from Telegraph Hill Partners.  

The funding will support new product development, an expansion of applications for single-cell characterization and isolation on the company's platforms, and the acceleration of commercial activities.  

Durham, North Carolina-based Cell Microsystems also plans to "significantly" increase headcount in the coming months with new hires in engineering, software systems, product applications, manufacturing, customer support, and commercial roles.  

"Cell Microsystems' CellRaft technology is an innovative, enabling platform for the high-growth single-cell analysis market," Rob Capone, venture partner at Telegraph Hill Partners, said in a statement. 

Cell Microsystems'  single-cell workflow product, the CellRaft AIR System, automates cloning workflows using brightfield imaging, eliminating the need for fluorescent markers for sorting and confluency measurement. The company signed an agreement with Bucher Biotec last year, allowing Bucher to exclusively distribute the CellRaft AIR System in Switzerland.  

The firm also offers its CytoSort consumable arrays for use on the CellRaft AIR system, and said that its products enable multiple single-cell discovery and development applications, including single cell isolation, CRISPR gene editing, “track and trace” clonal propagation, genomics, stem cell propagation and programming, and development of novel cell lines and organoids.